These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


120 related items for PubMed ID: 347330

  • 21. [Use of nicergoline (Sermion) in the treatment of migraine].
    Prusiński A, Durko A, Selmaj K.
    Wiad Lek; 1984 Mar 15; 37(6):420-2. PubMed ID: 6385484
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
    Coscia M.
    Minerva Cardioangiol; 1972 Sep 15; 20(9):497-504. PubMed ID: 4561065
    [No Abstract] [Full Text] [Related]

  • 24. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study.
    Battaglia A, Bruni G, Ardia A, Sacchetti G.
    J Am Geriatr Soc; 1989 Apr 15; 37(4):295-302. PubMed ID: 2646350
    [Abstract] [Full Text] [Related]

  • 25. [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].
    Kellner H.
    MMW Munch Med Wochenschr; 1976 Oct 22; 118(43):1399-1402. PubMed ID: 825745
    [Abstract] [Full Text] [Related]

  • 26. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
    Samsó Dies JM, Villa Badó J, Villalobos J, Iriarte JL, Ordeix R.
    Arzneimittelforschung; 1979 Oct 22; 29(8a):1301-7. PubMed ID: 540075
    [Abstract] [Full Text] [Related]

  • 27. [Nicergoline and cerebral performance insufficiency. Observations in 1 year treatment controls].
    Kugler J, Heidrich H.
    Fortschr Med; 1984 Nov 15; 102(42):1091-6. PubMed ID: 6392047
    [Abstract] [Full Text] [Related]

  • 28. [Use of sermion in cerebral atherosclerosis patients with a history of ischemic stroke].
    Tsimenko OA, Sosnov IuD, Kharchenko AP, Gaĭduk IuS.
    Vrach Delo; 1988 Jul 15; (7):24-7. PubMed ID: 3188456
    [No Abstract] [Full Text] [Related]

  • 29. [Therapy of demonstrated cerebral ischemia with nicergoline (Sermion)].
    Karyofilis A.
    Ther Ggw; 1980 Dec 15; 119(12):1478-85. PubMed ID: 7466692
    [No Abstract] [Full Text] [Related]

  • 30. [Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication].
    Meilhac B, Montestruc F, Aubin F, Djian F, Rouffy J.
    Therapie; 1997 Dec 15; 52(3):179-86. PubMed ID: 9366101
    [Abstract] [Full Text] [Related]

  • 31. [Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
    Pohle W, Hirche H, Barmeyer J, Schümichen C, Hoffmann G.
    Med Welt; 1979 Feb 16; 30(7):269-72. PubMed ID: 372733
    [No Abstract] [Full Text] [Related]

  • 32. [Use of nicergoline (IDB-1076) in the treatment of mild to moderate systemic arterial hypertension in adults and in the aged].
    Rinaldi G, Nieri A, Saponati G.
    Minerva Cardioangiol; 1987 Oct 16; 35(10):573-83. PubMed ID: 3438004
    [No Abstract] [Full Text] [Related]

  • 33. Symptomatic treatment of benign prostatic obstruction with nicergoline: a placebo controlled clinical study and urodynamic evaluation.
    Ronchi F, Margonato A, Ceccardi R, Rigatti P, Rossini BM.
    Urol Res; 1982 Oct 16; 10(3):131-4. PubMed ID: 6182672
    [Abstract] [Full Text] [Related]

  • 34. [Trial of nicergoline in arteriopathies of the lower limbs (apropos of 33 cases)].
    Debaert M, Ribet M, Quandalle P.
    Lille Med; 1981 Mar 16; 26(3):140-3. PubMed ID: 7289750
    [No Abstract] [Full Text] [Related]

  • 35. [Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)].
    Kaemmerer E.
    Nervenarzt; 1980 Jun 16; 51(6):368-72. PubMed ID: 7453888
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
    Friedman LM.
    Circulation; 1980 Dec 16; 62(6 Pt 2):V88-9. PubMed ID: 7002355
    [Abstract] [Full Text] [Related]

  • 38. [Conservative therapy of arterial occlusive diseases. Double-blind study on the effect of butalamine hydrochloride].
    Seboldt H.
    Fortschr Med; 1980 Feb 21; 98(7):257-60. PubMed ID: 6767648
    [Abstract] [Full Text] [Related]

  • 39. [Haemodynamic and metabolic effects of exercise test in diabetic patients with arteritis treated or not with nicergoline (author's transl)].
    Boismare F, Leclerc JL, Lefrançois J, Moore N, Paux G, Schrub JC, Vuillermet P.
    Sem Hop; 1980 Feb 21; 57(33-36):1455-7. PubMed ID: 6270809
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.